Rapid Reliable Testing (RRT), a business line of Ambulnz, Inc. d/b/a DocGo, has announced it is working with Carnival Corporation on COVID-19 testing and COVID-19 vaccines for crew members as it prepares for the restart of cruising in the U.S., with plans to also test guests once cruises resume.

RRT and Carnival Corporation, whose nine cruise line brands include namesake Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn in the U.S., have completed initial phases of a crew member testing process. RRT is facilitating on-site antigen tests, also known as rapid diagnostic tests, for all crew on 18 ships in the company’s fleet, an effort that may expand to additional ships.

“With the increase in vaccinations and people prepared to begin a return to normal life, DocGo is partnering with Carnival Corporation to prepare for the restart of cruising as one of the world’s most popular vacation options,” said Anthony Capone, president of DocGo. “Our reporting is fully integrated with SeaCare – the cruise industry’s leading emergency medical records system – to ensure a seamless experience.”

RRT has administered over 1.2 million COVID-19 tests in markets across the U.S. and it is testing tens of thousands of people per week at municipal and corporate testing sites across the country using a combination of PCR nasal swabs, saliva tests, and on-site rapid antigen tests. They are a leading provider of COVID vaccines in New York, Colorado, California, and Washington, having administered over 500,000 vaccine doses to date.